Galectin Therapeutics Stock Market Value
| GALT Stock | USD 2.84 0.07 2.53% |
| Symbol | Galectin |
Galectin Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Galectin Therapeutics. If investors know Galectin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Galectin Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.75) | Return On Assets (1.04) | Return On Equity (37.28) |
The market value of Galectin Therapeutics is measured differently than its book value, which is the value of Galectin that is recorded on the company's balance sheet. Investors also form their own opinion of Galectin Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Galectin Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Galectin Therapeutics' market value can be influenced by many factors that don't directly affect Galectin Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Galectin Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Galectin Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Galectin Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Galectin Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Galectin Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Galectin Therapeutics.
| 09/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Galectin Therapeutics on September 29, 2024 and sell it all today you would earn a total of 0.00 from holding Galectin Therapeutics or generate 0.0% return on investment in Galectin Therapeutics over 60 days. Galectin Therapeutics is related to or competes with Madrigal Pharmaceuticals, Viking Therapeutics, Sarepta Therapeutics, Hepion Pharmaceuticals, PTC Therapeutics, Terns Pharmaceuticals, and Akero Therapeutics. Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of thera... More
Galectin Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Galectin Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Galectin Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.93 | |||
| Information Ratio | 0.0151 | |||
| Maximum Drawdown | 16.57 | |||
| Value At Risk | (5.17) | |||
| Potential Upside | 5.9 |
Galectin Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Galectin Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Galectin Therapeutics' standard deviation. In reality, there are many statistical measures that can use Galectin Therapeutics historical prices to predict the future Galectin Therapeutics' volatility.| Risk Adjusted Performance | 0.0484 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.33) | |||
| Sortino Ratio | 0.0169 | |||
| Treynor Ratio | 0.1022 |
Galectin Therapeutics Backtested Returns
Currently, Galectin Therapeutics is slightly risky. Galectin Therapeutics holds Efficiency (Sharpe) Ratio of 0.0407, which attests that the entity had a 0.0407% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Galectin Therapeutics, which you can use to evaluate the volatility of the firm. Please check out Galectin Therapeutics' Downside Deviation of 2.93, market risk adjusted performance of 0.1122, and Risk Adjusted Performance of 0.0484 to validate if the risk estimate we provide is consistent with the expected return of 0.13%. Galectin Therapeutics has a performance score of 3 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 1.62, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Galectin Therapeutics will likely underperform. Galectin Therapeutics right now retains a risk of 3.09%. Please check out Galectin Therapeutics downside variance, and the relationship between the sortino ratio and accumulation distribution , to decide if Galectin Therapeutics will be following its current trending patterns.
Auto-correlation | -0.55 |
Good reverse predictability
Galectin Therapeutics has good reverse predictability. Overlapping area represents the amount of predictability between Galectin Therapeutics time series from 29th of September 2024 to 29th of October 2024 and 29th of October 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Galectin Therapeutics price movement. The serial correlation of -0.55 indicates that about 55.0% of current Galectin Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.55 | |
| Spearman Rank Test | -0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Galectin Therapeutics lagged returns against current returns
Autocorrelation, which is Galectin Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Galectin Therapeutics' stock expected returns. We can calculate the autocorrelation of Galectin Therapeutics returns to help us make a trade decision. For example, suppose you find that Galectin Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Galectin Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Galectin Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Galectin Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Galectin Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Galectin Therapeutics Lagged Returns
When evaluating Galectin Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Galectin Therapeutics stock have on its future price. Galectin Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Galectin Therapeutics autocorrelation shows the relationship between Galectin Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Galectin Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Galectin Stock Analysis
When running Galectin Therapeutics' price analysis, check to measure Galectin Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galectin Therapeutics is operating at the current time. Most of Galectin Therapeutics' value examination focuses on studying past and present price action to predict the probability of Galectin Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galectin Therapeutics' price. Additionally, you may evaluate how the addition of Galectin Therapeutics to your portfolios can decrease your overall portfolio volatility.